266 related articles for article (PubMed ID: 9607928)
1. Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset.
Haslett PA; Corral LG; Albert M; Kaplan G
J Exp Med; 1998 Jun; 187(11):1885-92. PubMed ID: 9607928
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide and a thalidomide analogue drug costimulate virus-specific CD8+ T cells in vitro.
Haslett PA; Hanekom WA; Muller G; Kaplan G
J Infect Dis; 2003 Mar; 187(6):946-55. PubMed ID: 12660941
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cells.
Marriott JB; Clarke IA; Dredge K; Muller G; Stirling D; Dalgleish AG
Clin Exp Immunol; 2002 Oct; 130(1):75-84. PubMed ID: 12296856
[TBL] [Abstract][Full Text] [Related]
4. The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody.
Jin Y; Fuller L; Carreno M; Esquenazi V; Tzakis AG; Miller J
Hum Immunol; 1998 Jun; 59(6):352-62. PubMed ID: 9634197
[TBL] [Abstract][Full Text] [Related]
5. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
6. Costimulation of CD3/TcR complex with either integrin or nonintegrin ligands protects CD4+ allergen-specific T-cell clones from programmed cell death.
Agea E; Bistoni O; Bini P; Migliorati G; Nicoletti I; Bassotti G; Riccardi C; Bertotto A; Spinozzi F
Allergy; 1995 Aug; 50(8):677-82. PubMed ID: 7503404
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory drug costimulates T cells via the B7-CD28 pathway.
LeBlanc R; Hideshima T; Catley LP; Shringarpure R; Burger R; Mitsiades N; Mitsiades C; Cheema P; Chauhan D; Richardson PG; Anderson KC; Munshi NC
Blood; 2004 Mar; 103(5):1787-90. PubMed ID: 14512311
[TBL] [Abstract][Full Text] [Related]
8. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
9. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
Wen T; Bukczynski J; Watts TH
J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
[TBL] [Abstract][Full Text] [Related]
10. Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation.
Haslett PA; Roche P; Butlin CR; Macdonald M; Shrestha N; Manandhar R; Lemaster J; Hawksworth R; Shah M; Lubinsky AS; Albert M; Worley J; Kaplan G
J Infect Dis; 2005 Dec; 192(12):2045-53. PubMed ID: 16288366
[TBL] [Abstract][Full Text] [Related]
11. Costimulation by purified intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 induces distinct proliferation, cytokine and cell surface antigen profiles in human "naive" and "memory" CD4+ T cells.
Semnani RT; Nutman TB; Hochman P; Shaw S; van Seventer GA
J Exp Med; 1994 Dec; 180(6):2125-35. PubMed ID: 7525848
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
Rich S; Seelig M; Lee HM; Lin J
J Immunol; 1995 Jul; 155(2):609-18. PubMed ID: 7608539
[TBL] [Abstract][Full Text] [Related]
13. Interleukin (IL) 4, in the absence of antigen stimulation, induces an anergy-like state in differentiated CD8+ TC1 cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines.
Sad S; Mosmann TR
J Exp Med; 1995 Nov; 182(5):1505-15. PubMed ID: 7595220
[TBL] [Abstract][Full Text] [Related]
14. Activation and re-activation potential of T cells responding to staphylococcal enterotoxin B.
Hamel ME; Eynon EE; Savelkoul HF; van Oudenaren A; Kruisbeek AM
Int Immunol; 1995 Jul; 7(7):1065-77. PubMed ID: 8527404
[TBL] [Abstract][Full Text] [Related]
15. Superantigens anergize cytokine production but not cytotoxicity in vivo.
Sundstedt A; Dohlsten M; Hedlund G; Höidén I; Björklund M; Kalland T
Immunology; 1994 May; 82(1):117-25. PubMed ID: 7913912
[TBL] [Abstract][Full Text] [Related]
16. Cytokine production by CD4+ and CD8+ T cells in mice following primary exposure to chemical allergens: evidence for functional differentiation of T lymphocytes in vivo.
Moussavi A; Dearman RJ; Kimber I; Kemeny DM
Int Arch Allergy Immunol; 1998 Jun; 116(2):116-23. PubMed ID: 9652304
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis.
Bekker LG; Haslett P; Maartens G; Steyn L; Kaplan G
J Infect Dis; 2000 Mar; 181(3):954-65. PubMed ID: 10720518
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
Makrigiannis AP; Musgrave BL; Hoskin DW
J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs.
Schafer PH; Gandhi AK; Loveland MA; Chen RS; Man HW; Schnetkamp PP; Wolbring G; Govinda S; Corral LG; Payvandi F; Muller GW; Stirling DI
J Pharmacol Exp Ther; 2003 Jun; 305(3):1222-32. PubMed ID: 12649301
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]